SOLENO THERAPEUT. DL-001 - Asset Resilience Ratio

Latest as of December 2025: 41.74%

SOLENO THERAPEUT. DL-001 (6XC) has an Asset Resilience Ratio of 41.74% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€235.37 Million

≈ $275.17 Million USD Cash + Short-term Investments

Total Assets

€563.83 Million

≈ $659.18 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2023–2025)

This chart shows how SOLENO THERAPEUT. DL-001's Asset Resilience Ratio has changed over time. Check 6XC capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down SOLENO THERAPEUT. DL-001's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SOLENO THERAPEUT. DL-001 market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€235.37 Million	41.74%
Total Liquid Assets	€235.37 Million	41.74%

Asset Resilience Insights

Very High Liquidity: SOLENO THERAPEUT. DL-001 maintains exceptional liquid asset reserves at 41.74% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

SOLENO THERAPEUT. DL-001 Industry Peers by Asset Resilience Ratio

Compare SOLENO THERAPEUT. DL-001's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Samsung Biologics Co Ltd KO:207940	Biotechnology	5.66%
Revolution Medicines Inc NASDAQ:RVMD	Biotechnology	65.10%
Abivax SA PA:ABVX	Biotechnology	2.34%
Asymchem Laboratories Tian Jin Co Ltd SHE:002821	Biotechnology	5.07%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	43.36%
REMEGEN CO. LTD YC 1 F:REG	Biotechnology	16.77%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%
Zhejiang Ausun Pharmaceutical Co Ltd SHG:603229	Biotechnology	0.12%

Annual Asset Resilience Ratio for SOLENO THERAPEUT. DL-001 (2023–2025)

The table below shows the annual Asset Resilience Ratio data for SOLENO THERAPEUT. DL-001.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	41.74%	€235.37 Million ≈ $275.17 Million	€563.83 Million ≈ $659.18 Million	-19.74pp
2024-12-31	61.49%	€203.51 Million ≈ $237.92 Million	€330.97 Million ≈ $386.94 Million	--
2023-12-31	0.00%	€0.00 ≈ $0.00	€180.69 Million ≈ $211.25 Million	--

pp = percentage points

About SOLENO THERAPEUT. DL-001

F:6XC Germany Biotechnology

Market Cap

$2.73 Billion

€2.34 Billion EUR

Market Cap Rank

#5608 Global

#884 in Germany

Share Price

€44.86

Change (1 day)

+1.70%

52-Week Range

€25.52 - €73.00

All Time High

€73.10